[ad_1]
San Diego, June 25, 2021 (Global News Agency)-
Johnson Fistel, LLP, a shareholder equity law firm, announced that it represents ChemoCentryx Inc. (“ChemoCentryx” or “Company”) (NASDAQ:China Chengxin International). The class action represents shareholders who purchased ChemoCentryx from November 26, 2019 to May 6, 2021 (both days inclusive) (“Class Action Period”).If you wish to serve as the lead plaintiff in this class action, you must July 6, 2021.
[Click here to join this action]
The complaint stated that the company failed to disclose to investors: (1) The research design of the Phase III ADVOCATE trial proposed…
The full story on Benzinga.com
[ad_2]
Source link
